相关实验视频
Updated: Jun 25, 2026

09:06
Intra-lymph Node Injection of Biodegradable Polymer Particles
Published on: January 3, 2014
滑剂添加剂功能的分子机制
Nicholas J Mosey1, Martin H Müser, Tom K Woo
1Department of Chemistry, University of Western Ontario, London, Ontario, Canada, N6A 5B7.
概括
研究人员发现滑剂中的抗磨损添加剂如何形成保护膜. 压力改变了原子的协调,形成了减少摩擦和磨损的网络,有助于设计出更好的环保添加剂.
科学领域:
- 部落学 (tribology) 是一个学科.
- 材料科学 材料科学 材料科学
- 计算化学的计算化学
背景情况:
- 机械磨损限制了带有移动部件的设备中部件的使用寿命.
- 含有添加剂的滑剂,如酸,通过形成保护性表面膜来减轻磨损.
- 了解这些防磨薄膜的分子机制对于提高其有效性和环境影响至关重要.
研究的目的:
- 阐明抗磨薄膜形成,功能和能量消耗的分子起源.
- 研究压力诱导的原子协调变化在网络形成中的作用.
- 为合理设计新型抗磨损添加剂提供机械基础.
主要方法:
- 使用了第一原则分子动力学模拟.
- 模拟集中在从商业防磨添加剂中获得的薄膜上.
- 分析的重点是原子协调,网络形成和能量消散机制.
主要成果:
- 防磨膜的性能与原子协调数的压力诱导变化有关.
- 这些变化促进了化学连接网络的形成,作为交叉连接器.
- 确定了一种解释薄膜形成,功能和能量消散的分子机制.
结论:
- 这项研究揭示了反磨损膜有效性背后的原子级机制.
- 压力诱导的网络形成是减少磨损的关键.
- 这种理解可以指导各种材料的先进,环保的抗磨损添加剂的开发.
相关概念视频
Surface Active Agents
Surfactants, named for their behavior at interfaces, positively adsorb at the interfaces of two phases, reducing interfacial tension. Their versatility as emulsifiers, detergents, and foaming agents stems from this ability. Surfactants, often termed amphiphiles, share the property of amphipathy, with molecules having both hydrophilic and hydrophobic portions. The hydrophilic part is called the head, and the hydrophobic part, including an elongated alkyl substituent, forms the tail.Surfactants...
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
Modified-Release Drug Delivery Systems: Influencing Factors
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

